Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV safety study of Jinhua Qinggan Granules for influenza
ChiCTR2100049909Phase 4Not yet recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- May 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of jinhua qinggan granules in influenza, sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoints: Adverse reaction rate, Types of adverse reactions and 1 more. Planned start May 2021; status: not yet recruiting.
02
Drugs
jinhua qinggan granules
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR2100049909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049909.